Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,9158881,AUC ratios,"The AUC ratios between CSF and plasma for hydroxyzine after intranasal and intra-arterial administration were 4.0 and 0.4, respectively.",Distribution of antihistamines into the CSF following intranasal delivery. ,AUCR-Q21,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9158881/),,4.0,27318,DB08936,Chlorcyclizine
,9158881,AUC ratios,"The AUC ratios between CSF and plasma for hydroxyzine after intranasal and intra-arterial administration were 4.0 and 0.4, respectively.",Distribution of antihistamines into the CSF following intranasal delivery. ,AUCR-Q21,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9158881/),,0.4,27319,DB08936,Chlorcyclizine
,9158881,AUC ratios,"The AUC ratios for triprolidine, the other antihistamine with measurable CSF concentrations, were 0.5 and 0.7, respectively.",Distribution of antihistamines into the CSF following intranasal delivery. ,AUCR-Q21,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9158881/),,0.5,27320,DB08936,Chlorcyclizine
,9158881,AUC ratios,"The AUC ratios for triprolidine, the other antihistamine with measurable CSF concentrations, were 0.5 and 0.7, respectively.",Distribution of antihistamines into the CSF following intranasal delivery. ,AUCR-Q21,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9158881/),,0.7,27321,DB08936,Chlorcyclizine
below,26599718,EC50,"Several compounds exhibited EC50 values below 10 nM against HCV infection, cytotoxicity selectivity indices above 2000, and showed improved in vivo pharmacokinetic properties.","Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection. ",EC50-Q16,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26599718/),nM,10,133295,DB08936,Chlorcyclizine
above,26599718,cytotoxicity selectivity indices,"Several compounds exhibited EC50 values below 10 nM against HCV infection, cytotoxicity selectivity indices above 2000, and showed improved in vivo pharmacokinetic properties.","Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26599718/),,2000,133296,DB08936,Chlorcyclizine
